BACKGROUND: The androgen-regulated probasin (PB) promoter has been used extensively to target transgenes to the prostate in transgenic mice; however, limited data exist on the mechanism that dictates prostate-specific gene expression. Tissue-specific gene expression involves synergistic effects among transcription factors associated in a complex bound to cis-acting DNA elements. METHODS: Using comprehensive linker scan mutagenesis, enzyme mobility shift and supershift assays, chromatin immunoprecipitation, and transgenic animal studies, we have extensively characterized the prostate-specific PB promoter. RESULTS: We identified a series of nonreceptor transcription factors that are bound to the prostate-specific rat PB promoter. These factors include several ubiquitously distributed proteins known to participate in steroid receptor-mediated transcription. In addition, we identified two tissue-specific DNA elements that are crucial in directing prostate-specific PB expression, and confirmed the functional importance of both elements in transgenic animal studies. These two elements are functionally interchangeable and can be bound by multiple protein complexes, including the forkhead transcription factor FoxA1, a "pioneer factor" that has a restricted distribution to some cells type that are ectoderm and endoderm in origin. Using transgenic mice, we further demonstrate that the minimal PB promoter region (-244/-96 bp) that encompasses these tissue-specific elements results in prostate-specific gene expression in transgenic mice, contains androgen receptor and FoxA1-binding sites, as well as ubiquitous transcription factor binding sites. CONCLUSION: We propose that these sequence-specific DNA-binding proteins, including tissue-restricted and ubiquitous factors, create the first level of transcriptional control, which responds to intracellular pathways that directs prostate-specific gene expression.
BACKGROUND: The androgen-regulated probasin (PB) promoter has been used extensively to target transgenes to the prostate in transgenic mice; however, limited data exist on the mechanism that dictates prostate-specific gene expression. Tissue-specific gene expression involves synergistic effects among transcription factors associated in a complex bound to cis-acting DNA elements. METHODS: Using comprehensive linker scan mutagenesis, enzyme mobility shift and supershift assays, chromatin immunoprecipitation, and transgenic animal studies, we have extensively characterized the prostate-specific PB promoter. RESULTS: We identified a series of nonreceptor transcription factors that are bound to the prostate-specific ratPB promoter. These factors include several ubiquitously distributed proteins known to participate in steroid receptor-mediated transcription. In addition, we identified two tissue-specific DNA elements that are crucial in directing prostate-specific PBexpression, and confirmed the functional importance of both elements in transgenic animal studies. These two elements are functionally interchangeable and can be bound by multiple protein complexes, including the forkhead transcription factor FoxA1, a "pioneer factor" that has a restricted distribution to some cells type that are ectoderm and endoderm in origin. Using transgenic mice, we further demonstrate that the minimal PB promoter region (-244/-96 bp) that encompasses these tissue-specific elements results in prostate-specific gene expression in transgenic mice, contains androgen receptor and FoxA1-binding sites, as well as ubiquitous transcription factor binding sites. CONCLUSION: We propose that these sequence-specific DNA-binding proteins, including tissue-restricted and ubiquitous factors, create the first level of transcriptional control, which responds to intracellular pathways that directs prostate-specific gene expression.
Authors: Lillian H Y Yeung; Jason T Read; Pernille Sorenson; Colleen C Nelson; William Jia; Paul S Rennie Journal: Biochem J Date: 2003-05-01 Impact factor: 3.857
Authors: Olga Klezovitch; John Chevillet; Janni Mirosevich; Richard L Roberts; Robert J Matusik; Valeri Vasioukhin Journal: Cancer Cell Date: 2004-08 Impact factor: 31.743
Authors: Nan Gao; Jianfeng Zhang; Mira A Rao; Thomas C Case; Janni Mirosevich; Yongqing Wang; Renjie Jin; Aparna Gupta; Paul S Rennie; Robert J Matusik Journal: Mol Endocrinol Date: 2003-05-15
Authors: Shunyou Wang; Jing Gao; Qunying Lei; Nora Rozengurt; Colin Pritchard; Jing Jiao; George V Thomas; Gang Li; Pradip Roy-Burman; Peter S Nelson; Xin Liu; Hong Wu Journal: Cancer Cell Date: 2003-09 Impact factor: 31.743
Authors: Katharine Ellwood-Yen; Thomas G Graeber; John Wongvipat; M Luisa Iruela-Arispe; JianFeng Zhang; Robert Matusik; George V Thomas; Charles L Sawyers Journal: Cancer Cell Date: 2003-09 Impact factor: 31.743
Authors: David J DeGraff; Magdalena M Grabowska; Tom C Case; Xiuping Yu; Mary K Herrick; William J Hayward; Douglas W Strand; Justin M Cates; Simon W Hayward; Nan Gao; Michael A Walter; Ralph Buttyan; Yajun Yi; Klaus H Kaestner; Robert J Matusik Journal: Lab Invest Date: 2014-05-19 Impact factor: 5.662
Authors: Paul M Levine; Eugine Lee; Alex Greenfield; Richard Bonneau; Susan K Logan; Michael J Garabedian; Kent Kirshenbaum Journal: ACS Chem Biol Date: 2012-08-07 Impact factor: 5.100
Authors: Jordy J Hsiao; Brandon H Ng; Melinda M Smits; Harryl D Martinez; Rohini J Jasavala; Izumi V Hinkson; Damian Fermin; Jimmy K Eng; Alexey I Nesvizhskii; Michael E Wright Journal: Mol Endocrinol Date: 2015-07-16
Authors: Magdalena M Grabowska; Amicia D Elliott; David J DeGraff; Philip D Anderson; Govindaraj Anumanthan; Hironobu Yamashita; Qian Sun; David B Friedman; David L Hachey; Xiuping Yu; Jonathan H Sheehan; Jung-Mo Ahn; Ganesh V Raj; David W Piston; Richard M Gronostajski; Robert J Matusik Journal: Mol Endocrinol Date: 2014-05-06
Authors: Jagpreet S Nanda; Wisam N Awadallah; Sarah E Kohrt; Petra Popovics; Justin M M Cates; Janni Mirosevich; Peter E Clark; Giovanna A Giannico; Magdalena M Grabowska Journal: Prostate Date: 2020-07-21 Impact factor: 4.104
Authors: Magdalena M Grabowska; Stephen M Kelly; Amy L Reese; Justin M Cates; Tom C Case; Jianghong Zhang; David J DeGraff; Douglas W Strand; Nicole L Miller; Peter E Clark; Simon W Hayward; Richard M Gronostajski; Philip D Anderson; Robert J Matusik Journal: Endocrinology Date: 2015-12-17 Impact factor: 4.736
Authors: Jingbo Qiao; Magdalena M Grabowska; Ingrid S Forestier-Roman; Janni Mirosevich; Thomas C Case; Dai H Chung; Justin M M Cates; Robert J Matusik; H Charles Manning; Renjie Jin Journal: Oncotarget Date: 2016-09-20